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Abstract 
Practice Problem: An estimated 6.5 million American adults ≥20 years of age have heart failure 
(HF) and worldwide 1 to 2% of the total healthcare budget is spent on HF. To improve outcomes 
and streamline the treatment of HF patients, The American Heart Association (AHA) joined with 
the American College of Cardiology (ACC) and created the Get With The Guidelines Program 
(GWTG). 
PICOT: The PICOT question that guided this project was in adult HF patients admitted to the 
cardiovascular unit under the care of the hospitalist service, does implementing an evidence-based 
practice (EBP) discharge medication protocol for physician use based on the AHA GWTG 
program’s HF discharge medication protocol, compared to no standardized discharge protocol, 
improve patients’ 30-day readmission rate, in 12 weeks?   
Evidence: Evidence from 10 studies supported implementing an evidence-based GDMT tool into 
a standardized HF discharge medication protocol for this project.  
Intervention: Education and encouragement of use of the AHA GWTG discharge medication 
protocol for HF in the electronic health record (EHR) was provided to a group of physicians on a 
cardiovascular unit. The intervention was over a four-week period and pre- and post-intervention 
protocol use was observed with specific measures analyzed for observation of improvement.  
Outcome: The results determined there was minimal statistical significance, however, there was a 
decrease in the financial measure of the cost of HF readmissions denoting a clinical significance.  
Conclusion: Continued use of a guideline-based discharge medication protocol, such as the one 
utilized in this project, is recommended based on the results and evidence provided in this project.  
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Implementation of an Evidence-Based Practice Discharge Medication Protocol 
 for Heart Failure Patients to Reduce 30-Day Readmissions  
Patients are diagnosed every day with heart failure (HF), a prominent form of heart 
disease. Since HF is a complex syndrome, it requires a multidisciplinary approach to assist in 
decision-making for each patient's treatment plan. To improve outcomes and streamline the 
treatment of HF patients, The American Heart Association (AHA) joined with the American 
College of Cardiology (ACC) and created the Get With The Guidelines Program (AHA, 2018). 
The program is used by hospitals to improve heart disease patients' care by promoting consistent 
adherence to the latest scientific treatment guidelines (AHA, 2018). This paper will evaluate the 
effects of utilizing a guideline-based discharge medication protocol within the patient’s electronic 
medical record (EMR) for the discharging provider.   
This evidence-based practice (EBP) change was intended to improve the outcomes for HF 
patients as an integral part of their comprehensive discharge plan. Utilizing a systems-level 
approach to affect change in a healthcare organization may translate the knowledge that exists 
supporting guideline-based HF management into standard discharge practice. Decreasing 
variation at discharge for HF patients by implementing a standardized discharge protocol has been 
associated with a better quality of care and decreased readmission rates (Basoor et al., 2013; 
Smith et al., 2020). Hospitalization is an opportunity to optimize HF therapy because it gives the 
physician a chance to consult with patients about the importance of adherence to HF medication 
and of regular monitoring (Cowie et al., 2017). The DNP project’s goal is to implement the 
discharge protocol to reduce 30-day readmission rates for HF-related causes. 
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Significance of the Practice Problem 
HF is a chronic, progressive condition in which the heart muscle cannot pump enough to 
meet the body's blood and oxygen needs (AHA, 2017). An estimated 6.5 million American adults 
≥20 years of age have HF (Benjamin et al., 2018 p. 7). The financial impact is enormous. 
Worldwide, 1 to 2% of the total healthcare budget is spent on HF (Lesyuk et al., 2018, p. 1). It is 
one of the most frequent causes of hospitalization and accounts for more than $30 billion of 
United States (US) healthcare expenditure annually (Reddy & Borlaug, 2019).  
The early post discharge period is a particularly high risk time that often leads to poor 
outcomes (Smith et al., 2020). An average of 22.3% of HF patients are readmitted to the hospital 
within 30 days at a mean cost of $14,631 per patient (Kilgore et al., 2017, pp. 65-66). At 
discharge, patients are often prescribed numerous medications and must make drastic lifestyle 
changes to improve their HF symptoms and outcomes. Also, there may be multiple comorbidities 
to be managed alongside the diagnosis of HF (Albert & Kozinn, 2018).  
The Affordable Care Act of 2010 recognized this as an essential issue (Affordable Care 
Act, 2010). The legislation instituted a program to reduce the readmission rates of conditions such 
as HF by penalizing providers for higher-than-average readmission rates. HF hospitalization is a 
severe burden on healthcare, consuming significant healthcare resources, inflicting substantial 
morbidity and mortality, and critically impacting the patient's quality of life (Cowie et al., 2017; 
Yancy et al., 2018). It is prudent for healthcare organizations to seek the best options to increase 
reimbursement for HF patients. These strategies must decrease the high cost for readmission and 
provide the best outcomes for patients. 
In the state of Florida, hospitalizations for HF among Medicare-eligible persons aged >65 
years were 38, 347 in 2016 (CDC, 2016). In comparison, over 1,747 people in Duval County, 
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Florida, were hospitalized in 2016 due to HF (Florida Department of Health, 2019). The hospital 
setting for the Doctor of Nurse Practice (DNP) project has identified a significant issue with 
increased readmissions of HF patients from 26.3% in 2019 to 28.2% in the first quarter of 2020 
(D. Stiffler, personal communication, May 2020). 
Currently, the organization where the EBP occurred has an "A" rating on the national 
Leapfrog annual survey of healthcare providers (The Leapfrog Group, 2020). An area of 
improvement identified as “well below the national average” is "communication about 
medication" (The Leapfrog Group, 2020). Implementing the use of a structured discharge 
medication protocol such as the AHA HF discharge medication protocol, in the EHR allowed 
physicians to initiate, add, and adjust medications before discharge. This change was intended to 
help patients achieve optimal therapy, reduce the chance of costly readmissions, and lead to better 
quality outcomes. An associated physician-led conversation with patients at discharge about the 
medication inclusion, combined with nursing’s reinforcement of the education at discharge sought 
to improve the organization’s medication scores on the Leapfrog survey.  
PICOT Question 
The evidence-based intervention answered the following question: In adult HF patients 
admitted to the cardiovascular unit under the care of the hospitalist service (P), does 
implementing an EBP discharge medication protocol for physician use based on the AHA’s 
GWTG program HF discharge medication protocol (I), compared to no standardized discharge 
protocol (C), improve patients’ 30-day readmission rate (O), in twelve weeks (T)?  
The patient population included in the EBP change project were adult inpatients at a for-
profit hospital in Jacksonville, Florida, who were diagnosed with HF and admitted to the 
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cardiovascular care unit. The patients included were under the medical care of the Team Health 
Hospitalist group.  
HF patients’ comprehension of discharge instructions is often inadequate (Regalbuto et al., 
2014). HF patients require clear guidance from both the physician and nurse on what medications 
and instructions to follow when returning home. Providing useful discharge instructions, proper 
dose up-titration, education about HF monitoring, and strict follow up decreases readmissions for 
HF (Basoor et al., 2013). A protocol is a system of rules that explain the correct conduct and 
procedures to be followed in formal situations (Merriam-Webster, 2020). Protocols include 
guidance based on evidence from novel drug therapies, a treatment algorithm with more care 
options, an updated approach to prevention, and essential updates regarding various forms of HF 
and inpatient comorbidities (Fonarow, 2011; Yancy et al., 2018; Zamorano & Lozano, 2015).  
The Center for Medicare and Medicaid Services (CMS, 2020) has developed a Hospital 
Readmissions Reduction Program (HRRP). This Medicare value-based purchasing program 
decreases payments to Inpatient Prospective Payment System (IPPS) at hospitals with excessive 
readmissions (CMS, 2020). IPPS links payment to quality healthcare. Readmission for HF under 
IPPS is an unplanned readmission within 30 days of discharge from the initial admission for HF, 
and patients who are readmitted to the same hospital or to another applicable acute care hospital 
for any reason (CMS, 2020).  
Evidence-based Change Model and Change Theory 
System-level practice change must be supported by a coalition of promoters who have 
decided upon their goal, identified the known predictors of the goal, and aligned the strategies and 
action steps accordingly to be sustainable (University of Texas, 2018). To form a coalition of 
reinforcement, a nurse-driven system-level evidence-based change project must connect with a 
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need of interest to gain physician involvement and adherence to project initiatives. Utilizing a 
well-developed and trusted evidence-based change model will make the difference in planning, 
implementing, and evaluating the project's intention. 
The Iowa Model (see Figure 1, Appendix A) is an evidence-based model developed by 
nurses, for nurses, to assist in incorporating successful strategies learned when undertaking 
research utilization projects (Iowa Model Collaborative et al., 2017). The Iowa Model was chosen 
because of its ease of use and focus on organizational-level change. The step-by-step 
implementation process is clearly outlined. Leaders start by identifying a problem such as 
increasing readmission rates of HF patients. They then investigate if this problem is a priority of 
the organization to improve. This was done through confirmation by administrative leadership in 
a formal letter. The project manager (PM) confirmed organizational interest and formed a team. 
Stakeholders were identified through collaboration with the PM’s preceptor. The team included 
the PM (student), preceptor, data analyst, hospitalist leader, cardiovascular nurse manager, and 
former HF clinic nurse practitioner. A search for evidence to support the change process was 
conducted (see Figure 2, Appendix A). The succeeding process was the designed appearance of 
the change. The PM synthesized and appraised the evidence for the most beneficial strategy to 
address the problem. The change was evaluated for appropriateness for the organization. The 
intervention plan was discussed with the key stakeholders to assess their support of 
implementation. The project results were presented to all stakeholders to encourage continued 
support of the protocol usage throughout the organization. Employing a systematic approach to 
integrating a discharge protocol into the routine of discharging HF patients will make the impact 
of the EBP outcome on the patients and the health system easier to follow and to assess for 
necessary changes. The project results were disseminated through a presentation to the key 
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stakeholders, submitted to nursing journals for publication, and submitted to present at an EBP 
nursing conference.  
In addition to having an EBP model to follow for the structure of change, a leader should 
understand change at the organizational level and have a theoretical basis to create a vision of 
change for all to understand (Titler, 2008). Difficult times in healthcare call for interprofessional 
collaboration to improve and sustain the best outcomes for safe and high-quality patient care 
(Wojciechowski et al., 2016).  
Lewin’s Three-Step Model for Change Management was selected as theoretical support 
because it is used by nurses for quality improvement projects to transform care (Wojciechowski et 
al., 2016). Lewin's theory proposed individuals and groups were influenced by restraining forces 
or obstacles. These were aimed at keeping the status quo. However, Lewin noted driving forces 
could be used as a positive push to cause change to happen (Lewin, 1951).  
The three steps of the model were unfreezing, change, and refreezing (Lewin, 1951). The 
discharge protocol implemented aimed to change the providers’ previous discharge process of 
orders for HF patients. Engaging medical practitioners to “unfreeze” their current practice 
requires strong influence and teamwork. These efforts may lessen the anxiety of the unknown to 
diminish the restraining forces. Involving the nursing team and leadership to "drive" the change 
and support the EBP project was intended to lead to the project's desired results. Finally, a 
“refreezing” of the new norm can continue to benefit the healthcare teams’ professional practice, 
improve patient health, and maximize future organizational outcomes for HF readmission rates.  
Evidence Search Strategy 
The search strategy used the University of St. Augustine (USA) Library’s databases: 
CINAHL Complete, PubMed, Elsevier, ScienceDirect, Academic Search Index, and Pub Med. 
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Reference indexing was also used to find reputable sources for support. The keywords used in the 
USA search were "heart failure" and "guidelines" in the title and "readmission" in the subject 
heading. The criteria peer-reviewed, English language, and publishing dates between 2010 and 
2020 were used to refine the search. Inclusion criteria were: articles that utilized the GWTG 
quality improvement program and those that used a checklist, protocol, or guideline-directed 
therapy to reduce readmissions. Exclusion criteria removed articles that did not directly correlate 
to the interventions, did not show evidence of reduced readmissions, or were duplicates. In the 
search through PubMed, the MeSH headings used were "patient readmission," "patient 
readmission/statistics," "numerical data," "heart failure," and "guidelines." The dates searched 
were 2010-2020, and the same inclusion and exclusion criteria were applied. The reference lists of 
studies included and systematic reviews identified in the search were carefully examined for 
further eligible studies (see Figure 2, Appendix A). 
Evidence Search Results and Evaluation 
Studies concerning the successful implementation of a HF discharge protocol to reduce 
readmissions proved to be challenging to obtain. Only 24 articles were found to support this EBP 
project.  
The rationale for inclusion was documented evidence of an improvement in HF patients' 
readmission or of other outcomes based on similar interventions. Guideline-directed therapy and 
protocols were also included as the proposed project's intent is to utilize direction from the 
GWTG discharge protocol (see Figure 3, Appendix A). The results included studies that needed 
to be generalizable to other HF discharge interventions, and medication optimization was a 
primary factor to be considered. Articles were excluded if they did not involve HF patients that 
were hospitalized and/or readmission outcomes.  
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In the 10 articles selected and appraised, the overall level of evidence, based on the Johns 
Hopkins Nursing Evidence-Based Practice Model and Guidelines (Dang & Dearholt, 2017), was 
mostly Level II, then Level III, with one Level I (see Figure 1, Appendix B). The quality grade of 
eight of the articles was a B, which is interpreted as good, reasonably consistent results, adequate 
sample size and control, and relatively decisive conclusions. Two of the articles were found to be 
a quality grade A, indicating the highest level of quality. The search strategy was limited due to 
the availability of studies focused on reducing the readmission rate of HF patients by specifically 
using a guideline-directed discharge protocol. Articles that did not have at least a quality grade of 
B were not considered for inclusion. Four articles demonstrated Level III evidence, which can be 
understood as having a well-designed study without randomization. Five articles were Level II, 
and one article was a Level I. These criteria were felt to indicate the potential for positive results 
if the project was accepted (see Appendix C).  
Themes from the Evidence 
The articles included as evidence for this project were born from studies completed in 
various hospital settings and with many sample sizes. Participant hospitals in the studies may 
have been enrolled in the GWTG-HF program or in a different guideline-directed HF 
management program. Surveys, observational studies, core measure comparison, implementation 
studies, and retrospective studies were some of the methods used to obtain data on HF patient 
outcomes.  
Themes from the evidence were examined as they directly related to the PICOT question 
(see Appendix D). The most prevalent theme from the literature was the high level of variability 
in how patients with HF have been prescribed treatment during their hospital stay and at discharge 
(Basoor et al., 2013; Cutshall et al., 2018; Deschaseaux et al., 2016; Gilstrap et al., 2018; 
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Heidenreich et al., 2014; Kociol et al., 2012; Yamaguchi et al., 2018). Discharge checklists were 
used by some facilities (Basoor et al., 2013; Kociol et al., 2012) to enhance the healthcare team’s 
ability to prescribe and order medications and to minimize the opportunity for missed guideline 
recommendations. Medications commonly used as the standard treatment for patients with HF 
with reduced ejection fraction (HFrEF) were beta-blockers (BB), neurohormonal agents, and 
diuretics (Heidenreich et al., 2014; Wang et al., 2011; Yamaguchi et al., 2018). Some studies 
found these medications were inconsistently prescribed (Cutshall et al., 2018; Gilstrap et al., 
2018; Heidenreich et al., 2014), not prescribed at all (Cutshall et al., 2018; Deschaseaux et al., 
2016; Gilstrap et al., 2018), and lacked the up-titration suggested by most HF guidelines (Basoor 
et al., 2013). The patient population was determined to be at risk for hypotension due to the BB’s, 
angiotensin converting enzyme inhibitors (ACE), or angiotensin II receptor blockers (ARB) 
commonly prescribed for HF (Gilstrap et al., 2018). The risk could have contributed to the 
hesitancy of patient adherence and of physician prescription in the studies. The irregular 
prescribing practice may be related to the lack of substantial evidence, indicating a need for 
guideline-directed medical therapy (GDMT) protocols to be implemented to assist in reducing HF 
readmission rates.  
Reducing readmission rates is a leading driver for healthcare organizations to employ 
actions that help HF patients. Achieving the recommended <20% readmission rate directed by 
most HF management programs has proven to be difficult (Bergethon et al., 2016). The studies 
reviewed reinforced how problematic it was to prevent HF patients from demonstrating 
worsening symptoms, which led to hospital readmissions (Cutshall et al., 2018; Gilstrap et al., 
2018; Kociol et al., 2012; Yamaguchi et al., 2018). Approximately 1 million hospitalizations a 
year are related to HF (Deschaseaux et al., 2016). Demonstrating lower readmission rates for the 
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HF patient population can lead to higher reimbursement rates and lower quality scoring for 
hospitals (Gilstrap et al., 2018). The Basoor et al. (2013) study with the highest level of quality 
evidence reported a significant reduction in 30-day and 6-month readmissions due to 
implementing a guideline-directed discharge checklist similar to the protocol implemented in this 
project. Other studies that focused on discharge intervention and GDMT did mention a decrease 
in readmission rates as an indicator of accomplishment (Bergethon et al., 2016; Kociol et al., 
2012).  
The literature review supported further investigation of quality improvement and systems-
level change initiatives utilizing evidence-based practices (Basoor et al., 2013; Deschaseaux et al., 
2016; Fonarow, 2011; Heidenreich et al., 2014; Kociol et al., 2012). Available evidence has been 
synthesized to demonstrate the potential of an EBP change to reduce readmissions of HF patients. 
This evidence supported implementing a discharge protocol using AHA’s GWTG 
recommendations at discharge. 
Practice Recommendations 
Rather than relying on physician preference and level of HF diagnosis, HF patient 
treatments should be individualized based on their specific needs and aligned with proven 
therapies to reduce symptoms (Basoor et al., 2013; Bergethon et al., 2016; Cutshall et al., 2018; 
Deschaseaux et al., 2016; Gilstrap et al., 2018; Heidenreich et al., 2014; Kociol et al., 2012; 
Yamaguchi et al., 2018). The evidence supported a need to address the reduction of HF 
readmissions in a systematic way. This was accomplished by implementing a discharge protocol 
to standardize and guide physicians treatments based on evidence-based guidelines from AHA 
recommendations (Basoor et al., 2013; Bergethon et al., 2016; Cutshall et al., 2018; Deschaseaux 
et al., 2016; Fonarow, 2011; Gilstrap et al., 2018; Heidenreich et al., 2014; Kociol et al., 2012; 
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Wang et al., 2011; Yamaguchi et al., 2018). It is common for HF patients to have comorbidities, 
such as high blood pressure, renal disease, diabetes, and noncompliance issues. Gilstrap et al. 
(2018) reported with Level II evidence the application of guidelines recommended for stable HF 
populations was increasingly limited for hospitalized patients by hypotension, renal dysfunction, 
and inotrope use, causing clinicians to frequently deviate from guideline use.    
Three good to high-quality studies with Level I and Level II evidence reported an 
association between GDMT with reduced readmissions (Basoor et al., 2013; Bergethon et al., 
2016; Kociol et al., 2012). However, Cutshall et al. (2018) indicated an increased length of stay 
among the GDMT patients, which indirectly supported the DNP project. Five studies identified as 
having good quality with Level II and Level III evidence identified a lack of consistent GDMT 
among the HF inpatient population (Cutshall et al., 2018; Deschaseaux et al., 2016; Gilstrap et al., 
2018; Kociol et al., 2012; Yamaguchi et al., 2018). To change healthcare provider practice and 
create a streamlined HF discharge plan, implementation strategies must be coupled with novel 
guideline dissemination and organized physician engagement strategies such as the ones found in 
the literature (Ellrodt et al., 2013). 
Increases in all quality measures were observed over time among patients in settings that 
consistently used the GWTG protocol. (Heidenreich et al., 2014; Kociol et al., 2012). Yamaguchi 
et al. (2018) categorized participants into three groups and compared their 1-year mortality rate. 
The results were: prescribed both an ACE-I/ARB (7.8%), either an ACE-I/ARB (19.6%), and 
neither (34.4%). A study by Basoor et al. (2013) documenting checklist utilization was appraised 
as having the highest level of evidence and highest quality grade. It supported the use of a 
standardized discharge protocol, which reduced 30-day readmission rates from 20% to 2%.  
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Strong evidence from the studies supported the feasibility of implementing an established 
evidence-based GDMT tool (such as the AHA GWTG-HF discharge protocol) into a standardized 
HF discharge medication protocol. The review further reinforced a need for urgent action to 
reduce guideline nonadherence for this at-risk patient population. The GWTG discharge  
medication protocol aimed to improve care quality while decreasing costs. Examples include 
length of stay, readmissions, negative patient outcomes (Ellrodt et al., 2013; Fonarow et al., 2012; 
Kociol et al., 2012; Yamaguchi et al., 2018).  
Project Setting 
The chosen facility for the project is part of an extensive for-profit healthcare system with 
21 hospitals across the country and one in the United Kingdom. The hospital resides in an urban 
setting with 454-bed capacity. It is competing with other sizeable acute care healthcare 
organizations to be the leading healthcare provider in northeastern Florida and in its hospital 
system division. The hospital’s mission mentions above all else, the organization is committed to 
the care and improvement of human life. This organization's vision is to be an excellent place for 
employees to work and an excellent place for physicians to practice medicine, resulting in an 
excellent place for patients to receive care. The leadership is dedicated to finding innovative ways 
to meet their community's healthcare needs, and both employees and leadership have a shared 
vision to reach the highest levels of quality care.  
The community served commands attention to HF, as it is an increasing issue for the 
population (Florida Department of Health, 2018). The rise of HF 30-day readmissions from 
26.3% in 2019 to 28.2% in the first quarter of 2020 is not easily explained by patient 
demographics or behaviors but does offer an urgency to act (D. Stiffler, personal communication, 
May 2020). 
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The institution's organizational structure consists of an executive team under the authority 
of the board of trustees. Despite being a small part of an extensive healthcare system, this hospital 
has a strong sense of community and dedication of its staff to delivering a quality healthcare 
product. The stakeholders in this hospital that have partnered with the PM were crucial to the 
success and sustainability of the intervention (see Table 1 p.15).  
Table 1.  
Key Stakeholders 
 
Support of the project was confirmed by a written agreement between the PM, preceptor, 
and the Facility Medical Director of Hospital Services Department before implementation, and 
approval for continued sustainability has been established by leadership and the medical team 
since results have been shared. Sustainability was encouraged through the future use of a system-
wide HF discharge protocol for practitioners. Compliance is intended to be enforced by the 
cardiovascular and hospitalist leaders. The charge nurse on the cardiovascular unit where the 
project was implemented is to continue recommending the discharge protocol upon daily 
rounding with the physicians when a patient is identified as having a diagnosis of HF.  
The level of interprofessional collaboration for this project was high. It required a 
physician's commitment to participate, administrative-level approval, informatics support, nursing 
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guidance and recognition, and financial backing to take each team member's time away from 
current initiatives. This collaborative effort allowed participants to achieve together more than 
they can individually, to serve a larger group of people, and to grow at individual and 
organizational levels through systematic evidence-based change (Green & Johnson, 2015).  
Strengths, opportunities, weaknesses, and threats were identified that may have affected 
the project's planning, implementation, and execution phases (see Appendix F). The biggest 
obstacle identified that the project faced was practitioner resistance to change due to high patient 
volume and stressful working conditions exacerbated by the Covid-19 pandemic. The 
organization was focused on staffing for optimal support of high-risk patients and on preventing 
the spread of COVID-19. The intentions for the project were to highlight the need to address the 
worsening issue of HF patient outcomes and take action with a proactive, evidence-based plan.  
Project Overview 
The DNP project's mission was "To provide HF patients a considerate, evidence-based 
discharge medication regimen to reduce their chance of 30-day readmission”. The DNP project's 
vision was "Purposeful reduction in HF patient complications through collaborative, guideline-
based efforts in patient care excellence." These statements directly align with the organization's 
mission and vision as the patient is the focus for improvement.  
The project's short-term objective was to implement a HF discharge protocol in the 
hospital's cardiovascular unit. The long-term objective was to employ the continued use of a 
sustainable system-wide HF discharge protocol to reduce 30-day HF readmissions. The risk of 
such an ambitious goal is that HF patients are known for their multiple comorbidities and non-
compliance due to strict medication regimens, diet, and self-monitoring (Sevinc & Samancioglu, 
2017).  
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The risk for unintended consequences was addressed by educating the Hospitalist’s group 
prior to implementation that complicated HF patients’ discharge medication should be scrutinized 
based on laboratory values identified in the GWTG-HF protocol and documented if 
contraindications existed. If questions arise, then a conversation with the consulting cardiologist 
was recommended per AHA guidelines.  
Project Plan (Method) 
A nurse's ability to turn evidence into practice can be difficult if they have not mastered 
obtaining and appraising evidence. The Iowa Model (see Appendix A, Figure 1) guides clinical 
decision-making for healthcare professionals and the EBP process from both the clinician and 
systems perspectives (Iowa Model Collaborative et al., 2017). This model was chosen for this 
project because of its ease of use and focus on organizational-level change. The Iowa Model also 
offered a heuristic process for the investigator to gain a greater understanding of what kind of 
change agent they may be in their future leadership role. The model’s use of a systematic 
approach was helpful to this particular project as it was essential to determine the project’s impact 
on the patients’ health and the system's outcomes. The following section is an outline of how the 
model guided the EBP project.  
Step 1: Identify Triggering Issues/Opportunities 
 The PM identified a need to address the increasing 30-day readmission rate for HF 
patients at the specific facility. The issue of increasing HF readmissions at this specific facility 
was highlighted in a quality measures report and shared with the division. Efforts have been made 
to improve HF patient outcomes but have yet to produce positive results in this population. 
According to Suter et al. (2014), 30-day readmissions are costly to healthcare organizations and 
are likely to occur in one out of every four patients (p. 1333). 
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Step 2: State the Question or Purpose 
 The project aimed to determine if "In HF patients, does implementing an EBP discharge 
medication protocol for physician use, compared to no standardized discharge medication 
protocol, improve patients’ 30-day readmission rate, in twelve weeks?”.  
Step 3: Form a Team 
 The individuals identified as team members are not identical to the list of key 
stakeholders. The selection of team members requires consideration of interprofessional 
involvement, and of the skill sets required to plan, conduct, and evaluate the project (Iowa Model 
Collaborative et al., 2017). The project's active phases of planning, implementation, evaluation, 
and dissemination required a diverse set of skill sets and engagement in improving HF patients’ 
outcomes.  
The PM has over 10 years of nursing leadership experience. The PM has worked with 
many of the stakeholders for over 2 years and has established trust. The team was formed to 
include the PM, preceptor, and data analyst. 
Step 4: Assemble, Appraise and Synthesize Body of Evidence 
 It is imperative to appraise the entire body of evidence to gain sufficient knowledge of 
potential barriers and successes (Dang & Dearholt, 2017). The John Hopkins Nursing Evidence-
Based Practice Guidelines has assisted this phase (see Figure 1 Appendix B). 
Step 5: Is there Sufficient Evidence? 
This step can be seen as both subjective and objective depending upon the evaluator. 
Weighing of the evidence involves incorporating multiple types of evidence as part of the initial 
evidence review, evaluating evidence quality, quantity, and consistency (Iowa Model 
Collaborative et al., 2017). There is sufficient supportive evidence for utilizing AHA's GWTG HF 
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protocol in reducing 30-day readmission rates (Bergethon et al., 2016; Kociol et al., 2012; Wang 
et al., 2011). There is high-quality evidence backing the GDMT in reducing 30-day readmission 
rates and outcomes for HF patients (Basoor et al., 2013; Fonarow et al., 2012). There is abundant 
evidence highlighting the need for consistent GDMT at discharge for HF patients (Cutshall et al., 
2018; Deschaseaux et al., 2016; Fonarow et al., 2012; Gilstrap et al., 2018; Heidenreich et al., 
2014; Wang et al., 2011). The PICOT question was supported by the evidence. 
Step 6: Design the Practice Change 
 An interview with the key stakeholders about the plausibility and support for the initiative 
provided insight into the project design. A practice change was created that did not lead to staff 
rebellion. Organizational infrastructure and the commitment of resources was assessed throughout 
the project. It was important to identify all the possible gaps that needed to be filled before 
implementation (Iowa Model Collaborative et al., 2017). 
Step 7: Is Change Appropriate for Adoption in Practice? 
 The judgment of whether or not the project was appropriate for practice was dependent on 
many factors including the results of the statistical analyses, clinical significance, and the practice 
change’s effect on the unit’s culture. A consistent feedback loop between the PM, physicians, data 
analyst, and key stakeholders was enforced. The results of the project were summarized and 
disseminated to select members of the organization for a potential future system-wide 
implementation. 
Step 8: Integrate and Sustain the Practice Change 
 The integration of change requires ongoing engagement of the team members after the 
project is completed with continuous evaluation of key performance indicators. In this project, the 
Hospitalist Group buy-in was significant to the results of the practice change. The charge nurse on 
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the cardiovascular unit was encouraged to educate and remind the rounding practitioner to use the 
discharge protocol. A continuance of use of the protocol was recommended, and practitioners 
were educated on its benefits and use requirements. 
Step 9: Disseminate the Results 
Results were disseminated to key stakeholders and team members. The information 
presented to key stakeholders was in a formal format at the Executive Cardiovascular Committee 
meeting and sent in a Power Point presentation to all key stakeholders. The project manager will 
pursue publication for this project.  
The planning, initial data collection, and submission for approval was completed within 
four weeks of the project's implementation and the remainder of the data collection occurring 
throughout the implementation phase and 30 days post to capture any readmissions (see Table 
A1). Analysis and measurement of data was necessary after the last phase and continued until 
interpretation of the results were clear. 
 The project budget included the cost of wages for the utilization of team members' time to 
assist in the collection and organization of data. The discharge protocol was embedded in the 
organization's EHR, so there was no cost for customization of the EHR. There was minimal cost 
to the organization (see Table A3). 
 The timeline of the project was broken into three phases and extends from identification of 
the practice problem until dissemination of the evidence. The first phase was where the problem 
was identified, the organization was evaluated for readiness for an EBP change project, evidence 
was found to support an EBP change, and a plan was created for the project. The second phase 
consisted of organizational approval for the intended EBP change, IRB approval, stakeholder 
engagement, and implementation. The PM used a 4-week timeframe for implementation. The 
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final phase included data collection, data evaluation, evaluation of plan for sustainability, and 
dissemination of the findings. All three phases concluded April of 2021. (see Appendix E). 
Results 
The following section describes the data collection, evaluation, analysis, and the 
interpretation for significance. 
Data Collection and Analysis  
Data collection and review occurred retrospectively for 4 weeks prior to and 4 weeks after 
implementation of the AHA GWTG-HF protocol; 30-day readmission rates were assessed post 
intervention. Baseline measurements were collected using chart audits of all HF diagnosed 
patients in the cardiovascular unit under the Team Health hospitalists’ care and were compared to 
data collected throughout the implementation phase. All HF admissions were documented 30-
days post-intervention to capture patient readmissions. In all project phases, data were collected to 
evaluate the outcomes of improvement in the 30-day readmission HF patient readmission rate and 
protocol usage (see Table A1). Necessary data was transferred to an Intellectus software 
spreadsheet for analysis (see Table A2). 
Recruitment, Selection of Participants and Approvals 
Inclusion criteria were specific to project dates and included adult patients between 18 and 
100 years of age, similar to AHA GWTG HF guideline inclusion criteria. Patients were included 
if they were admitted to the cardiovascular unit, under the Team Health hospitalist care, and had a 
HF diagnosis. Patients were excluded if they were upgraded to another unit, discharged by a 
physician other than a hospitalist, admitted to hospice service, or deceased. The medical record 
number identified the patients. No personal identification information was collected.  
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The approval process for the USAHS Evidence-based Practice Review Council (EPRC) 
included submitting endorsements received from the facility where the project was to be 
implemented and authorization of use for the Iowa Model and the AHA-GWTG discharge 
protocol. The Team Health Hospitalist leader and the Cardiovascular Service Line Administrator 
gave written project approval.   
Participants in Data Collection and Analysis  
The PM collected patient information from the EHR. The analyst responsible for entering 
data into other cardiac registries collected specific daily reports from the quality department. The 
reports identified all patients admitted and coded with a diagnosis of HF in the specified date 
range. Reports were provided to the PM weekly.  
Data Storage and Misplacement 
Spreadsheet programs are valuable tools for entering, organizing, and storing data 
(Broman & Woo, 2018). Non-specific patient data was stored in the PM’s personal computer 
within an Excel spreadsheet and Intellectus software. The PM was the only team member with 
access to the data to ensure process integrity. Daily patient reports were returned to the analyst 
after data extraction for disposal. The PM reviewed all patients admitted during the 
implementation phase to ensure no HF patients were omitted. No missing data was found.  
Integrity of the Data 
 The PM validated data integrity of daily reports weekly by applying current methods to 
identify HF hospital patients through the Meditech EHR.  
Evaluation Design, Tools, and Type of Data 
The project used a pre- and post-design to evaluate the impact of the intervention 
(Stratton, 2019). Primary data examined included a mixture of continuous and discrete variables 
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presented as standard deviations, frequencies, means, and percentages (Giuliano & Polanowicz, 
2008). Descriptive data were nominal, ordinal, and continuous (Marshall & Jonker, 2010). 
Variables were analyzed using descriptive, comparison, and non-parametric statistics. 
Categories of Measure 
The outcome measure was the 30-day readmission rate for HF patients both pre, post, and 
for 30 days after the end of the implementation phase (Stratton, 2019). Balancing, process, 
financial, and sustainability measures were analyzed. Benchmarks were recorded based on pre-
intervention data (see Appendix G). 
Data Analysis 
Descriptive statistics, paired t-tests, and chi-square tests were used to analyze the data 
(Vetter & Mascha, 2018). “N” indicated the patient was not readmitted and “Y” indicated the 
patient was readmitted (see Appendix H, Table 1). Results of the Chi-square test were not 
statistically significant based on an alpha value of 0.05, χ2(2) = 1.11, p = 0.573. These suggested 
the primary outcome measure (30-day readmission) and phase were independent of one another 
(Intellectus Statistics, 2019). This further implied the observed frequencies were not significantly 
different than the anticipated frequencies. None of the data in the 30-day intervals met the target 
of at least a 20 percent reduction of the 30-day readmission rate (see Table H2) 
The process measure of HF discharge protocol utilization was analyzed using a two-tailed 
paired samples t-test (Intellectus Statistics, 2019). The result was statistically significant based on 
an alpha value of 0.05, t (12) = -6.68, p < .001, indicating the null hypothesis could be rejected 
(see Appendix H, Table 3 and Figure 1). Descriptive analysis of the number of times the protocol 
was used indicated an average of 1.46 (SD = 1.71, SEM = 0.48, Min = 0.00, Max = 6.00, 
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Skewness = 1.41, Kurtosis = 1.75). The target of 95% usage in each week was never reached (see 
Table H4). 
An insufficient number of observations was identified when performing descriptive 
statistics on the balancing measure of number of HF patients identified. Frequencies and 
percentages were calculated (Intellectus Statistics, 2019). “N” indicated the protocol was not 
mentioned to the rounding physician, and “Y” indicated the protocol was mentioned (see Table 
H5). No data was collected during the fifth 2-week period as it was post-intervention assessment 
time.  
The financial measure was analyzed using the mean cost of readmission per patient of 
$14,631 (see Table H6). These percentage reductions surpassed the target of 20% per 30-day 
period. Sustainability of the use of the protocol 30-days after the intervention period (Trimester 3) 
was measured using frequencies and percentages. “N” represented the protocol not being used 
(see Figure H2). The target goal of at least 95% usage was not met.  
Statistical and Clinically Significant Results 
The only test that produced a statistically significant result was the two-tailed paired 
samples t-test for the process measure (Intellectus Statistics, 2019). This indicated the null 
hypothesis could be rejected. The outcome of the p value must be less than 5% for the 
intervention to be deemed statistically significant (Andrade, 2019). The p value was >0.001. 
Considering the small sample size in the last two phases, clinical significance can be 
partially assumed. With reminders to physicians, there was a 40% increase in use of the protocol. 
This indicated the importance of communication between the nurse and physician to improve HF 
management at discharge. Unfortunately, after the intervention phase, there was a 37% decrease 
in protocol usage. The 30-day readmission rate did not meet the goal of a 20% reduction from the 
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benchmark measure; however, it did result in a 10% reduction comparing pre-intervention 30-day 
readmission rates to the last 30 days observed. Overall, this can be seen as an improvement in the 
outcome measure. 
The most obvious clinically significant finding was the financial measure. The decrease in 
cost of readmissions for each 90-day period was 30% and 29% respectively, which exceeded the 
project’s goal of 20% decrease. This may represent an attractive amount of savings for the 
hospital and support continued protocol use. 
Formative and Summative Criteria 
The GWTG registry collects achievement and quality data from organizations that 
participate in their program (AHA, 2020). This includes, but is not limited to, prescribing of ACE, 
ARB, aldosterone antagonist (AA), and evidence-based specific BB at discharge. The PM 
collected these formative results in the pre- and post-intervention phases and will share the data 
with key stakeholders. Summative criteria were results of benchmarking measures.  
Extraneous Variables 
The PM controlled for extraneous variables by using only a single inpatient unit, patients 
discharged from the hospitalist group, and data needed for evaluation. This reduced the number of 
participants for data collection.  
Protection of Human Subjects 
Patient data were not collected until approval was received from the EPRC of USAHS. 
This ensured the ethical safety of the project. The hospital where the project was implemented did 
not have an IRB.  
 
 
IMPLEMENTATION OF DISCHARGE PROTOCOL                                                                 27 
 
Impact 
 HF is a problem not easily solved. The facility previously identified the value of the 
evidence-based medication guidelines by having the recommended protocol medications 
embedded into each patient discharge summary. This made a smooth transition for the PM to 
reinforce its use. Hardwiring a new practice for this facility’s Team Health Hospitalists group was 
not as smooth.  
Before the project, the PM identified through data collection that usage of the existing tool 
was minimal (see Table H4). Her efforts to encourage protocol usage were not impactful enough 
sustain increased use of the HF protocol. Physician noncompliance during the intervention phase 
was discussed with their leadership. After formal presentation of results, there was discussion 
amongst the medical team that supported future protocol use. 
Review of the 30-day readmission rate indicated no statistically significant difference 
associated with the intervention. However, there was a decrease in the actual readmission rate 
from pre to post intervention (see Table H1). Reducing hospital readmissions for HF patients is a 
national priority, and quality improvement efforts are targeting reductions of ≥20% (Bergethon et 
al., 2016). This project documented a trend of high HF patient readmission rates at this facility. 
None of the project phases ever reached a 30-day readmission rate lower than 26% (see Table 
H1). However, the literature supported that consistent use of the discharge medication protocol 
will lead to a decreased 30-day readmission rates in HF (Basoor et al., 2013; Kociol et al., 2012). 
Future Implications 
The reduction in the readmission cost to the facility between each 30-day period was 
never less than 29% (see Table H6), and this represented a significant savings for the hospital. If 
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the HF discharge medication protocol occurred at the enterprise-level, then the cost savings would 
be substantial. 
The PM’s preceptor stated since the conclusion of the EBP project that the organization is 
beginning to present a quality improvement initiative on the selection of the AHA-GWTG HF 
medications that directly relates to reimbursement objectives. Upon discharge, HF patients must 
have each one of the categories of medication (ACE/ARB/ARNI, BB, and AA) selected by 
physicians, which aligns with this project’s specific goals. Combining reimbursement reduction 
with an organizational drive for guideline adherence will assist in optimizing the reduction of 30-
day readmission rates for HF patients. The presentation of this project’s results reminded the 
stakeholders of the evidence supporting the intervention and provided a potential structure for 
strategic efforts to improve HF patient outcomes. 
Limitations 
 Limitations that occurred during the EBP project are as follows: First, there was a limited 
area of surveillance (1 inpatient unit). Had the project involved several units, or the entire 
population of HF patients, the number of observations would have been more significant. The 
facility may consider employing the recommended practice change to all HF patient discharges to 
evaluate for a more significant reduction in readmissions. 
Secondly, the time of the project’s intervention was interrupted by a global pandemic of 
COVID-19. The priority of the hospital administration and staff revolved around controlling the 
spread of infection due to COVID-19, and caring for those affected with the illness. New 
initiatives were secondary to managing this novel virus with an already limited supply of staffing. 
Recently, the numbers of hospitalized patients with COVID-19 have decreased and the facility is 
back to focusing on other priorities. Since dissemination of results, the continuation of GDMT 
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with the GWTG-HF discharge protocol may become an organizational focus leading to 
sustainability of the change. Support for this continued initiative is relevant due to GDMT for HF 
becoming a recent topic of discussion in recent cardiovascular committee meetings. 
Thirdly, the evidence of poor utilization of GDMT by the facility physicians prior to the 
initiation of the change represents another limitation. A history of inadequate adherence to 
practice standards with limited oversight and accountability is contradictory to a sustainable 
practice change. This is an issue leadership may address as the results of this project represent a 
failure of compliance with recommended guidelines and insubordination. Further study of  
physician engagement in protocol utilization is needed to identify if a statistical significance truly 
exists between the protocol and the 30-day readmission rate. 
The holiday season being concurrent with the implementation phase may have affected the 
results. Difficulty adhering to a restricted diet during the holidays and not wanting to be in the 
hospital during the holiday season may be related to the results. The high readmission rate that 
continued throughout the project phases may have been due to the “holiday effect” some HF 
patients experience (Reedman et al., 2008).  
Finally, the PM not being employed where the project was implemented was found to be a 
significant limitation. If the PM worked at the facility there would have been daily observance 
and encouragement of the protocol with both the physicians and nursing staff. Established 
relationships can assist in buy-in and a deeper engagement of stakeholders (Rycroft-Malone et al., 
2016).  
 The limitations identified may have affected the statistical significance of the project 
results but did not affect the importance of the practice problem of HF readmissions. The project 
has highlighted the availability of a tool within their EHR that discharging practitioners can use to 
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better manage HF patient outcomes while not drastically altering their current practice. 
Discharging a HF patient can be standardized with this GDMT, with the exception of individual 
identified exclusionary criteria.  
Plans for Dissemination 
The results of this evidence-based practice change project will be shared both internally 
and externally of the organization. All team members will receive a presentation with PowerPoint 
slides emailed to them. The Cardiovascular Executive Committee was presented with a face-to-
face explanation and presentation of results at the March meeting, facilitated by the PM’s 
preceptor. This internal dissemination will be done to enhance awareness, create a clear 
understanding of the intervention’s benefits to the organization, identify areas of improvement in 
addressing the practice problem, and help motivate the organization to sustain the EBP change.  
The external dissemination of results will be sought through two nursing publications, one 
supported by the American Nurses Association (ANA) and the other supported by the AHA.  
First, the Online Journal of Issues in Nursing (OJIN) is described as “an online publication that 
reaches nursing professionals around the world” (American Nurses Association, 2020 ). This 
monthly, peer-reviewed journal, enhances comprehensive knowledge of topics relevant to nursing 
and helps build up a shared knowledge base (American Nurses Association, n.d.).  
The second nursing publication that will be considered for submission is the American 
Journal of Nursing (AJN). The AJN reaches more nurses than any other nursing journal through 
powerful print, website, institution, and social media channels (Lippincott Williams & 
Wilkins.org, 2020). It is viewed in Ovid, the institutional platform used by health systems and 
libraries. This is significant because all healthcare personnel can have access to the information 
provided by the project.  
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This scholarly work will also be submitted to The University of St. Augustine’s 
institutional repository called SOAR@USA. This is an opportunity for the project manager to 
display the completed work to the public alongside other works from the university’s students, 
faculty and alumni. 
The opportunity to present at conferences will be sought at the state and national level. 
Locally, the Florida Nurses Association hosts an annual Nursing Research and EBP Conference 
that would be the appropriate forum for the dissemination of findings. On a national scale, the 
American Nurses Credentialing Center hosts a virtual summit. This includes nurses from around 
the country who are provided the forum to present their work via the internet to empower 
professionalism and continued knowledge growth without having to travel. The flexibility and 
convenience of this virtual option allows for a broader audience to be reached while adhering to 
the current social distancing requirements.  
Conclusion 
HF’s burden affects healthcare organizations on many levels. The impetus for this EBP 
change project is the failure of the organizational efforts to reduce 30-day readmission rates for 
their HF patient population. Conformity with quality measures such as the AHA’s GWTH-HF 
discharge medication protocol has shown improvements with clinical outcomes (Fonarow, 2011). 
The problem has been identified and sufficient evidence has been found to support the 
intervention planned. Organizational readiness will be further assessed to establish a supportive 
environment for the systems-based EBP change. Forming a team of motivated system-wide 
interdisciplinary professionals will be essential. Standardization of HF patient discharge 
medications using a guideline-directed protocol, as detailed in the steps of this project, can be the 
needed change to address the costly cycle of a HF patients’ disease in all healthcare organizations.  
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EXPENSES  REVENUE  
Direct   Institutional budget support $3670 
Salary and benefits of staff for 
meetings.  
Approx. 6 hrs of meetings 
• Key stakeholders (see Table 1.) 
4hrs/avg hourly pay $60 
• 5 CVU charge nurses 2hrs/avg 
hourly pay $37 











Total Expenses $3670 Total Revenue $3670 
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Figure A1.  
 
The Iowa Model Revised 
 
 
Note. Iowa flow chart diagram from “Iowa Model of Evidence-Based Practice.” Iowa Model Collaborative. (2017). 
Iowa model of evidence-based practice: Revisions and validation. Worldviews on Evidence-Based Nursing, 
14(3), 175-182. Doi:10.1111/wvn.12223. Copyright 2015 by University of Iowa Hospitals and Clinics. 










Records identified through advanced search of University 
of St. Augustine for Health Sciences database searching 
heart failure, guidelines, readmission 




























Additional records identified through 
other sources such as reference 
searches 
(n = 4) 
Records after duplicates removed 
(n =26) 
Records screened 
(n = 26) Records excluded 
(n =16) 
Full-text articles assessed for eligibility 
(n =10) 
Full-text articles excluded, with reasons 
(n =0) 
Studies included in qualitative synthesis 
(n =10) 
Studies included in quantitative synthesis (meta-analysis) 
(n =10) 
Note. Prisma flow chart diagram from “Preferred Reporting Items for Systematic 
Reviews and Meta-analyses: The PRISMA Statement,” by D. Moher, A. Liberati, J. 
Tetzlaff, & D. G. Altman, 2009, Annals of Internal Medicine, 151(4), p. 267 
(http://dx.doi.org/10.7326/0003-4819-151-4-200908180-00135). Copyright 2009 by The 
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Figure 1  
















Data Extraction and 
Analysis 
Key Findings Usefulness/Recommendation/ 
Implications 







participates in the 





are the common 




None 100 randomly selected 
hospitals participating 
in GWTG. Patients 
were eligible for 
inclusion in the registry 
if they were admitted 
to a hospital for an 
episode of worsening 
heart failure or 
developed significant 
heart failure symptoms 
during a hospitalization 
for which heart failure 
was the primary 
discharge diagnosis. 
Used a telephone survey 
developed for this study 
and administered the 
survey to personnel at 
randomly selected 
hospitals participating in 
the GWTG-HF quality 
improvement initiative. 
We present hospital 
characteristics by 
readmission quartile, 
using means with SDs for 





between quartiles and all 
variables using Cochran-
Mantel-Haenszel nonzero 
correlation tests. Scored 
in each domain overall 
and by readmission 
quartile. Assessed 
associations between 




correlation tests. Tested 
for associations between 







and transitional care 
processes and lower 
30-day readmission 
rates (Kociol et al., 
2012) 
The use of computerized reminders 
and discharge checklists was used in 
<50% of the sites surveyed. 
Computerized discharge instructions 
or pop-up reminders to prescribe 
evidence-based therapies were only 
used by 24% and 18% of hospitals, 
respectively (Kociol et al., 2012). This 
shows a lack in use of tools provided 
by GWTG, and need for further 
studies based on the effectiveness of 











with heart failure 
(HF) guidelines 






None All patients admitted to 
the HF services of 
either hospital during 
the study period with a 
primary diagnosis of 
HF were considered for 
inclusion. Exclusion 
criteria included new‐
onset HF, end‐stage 
renal disease requiring 
hemodialysis, or end‐
stage HF requiring 





circulatory support or 
transplantation, were 
also excluded. 
Data collection methods 
not shared. Descriptive 
statistics are reported with 
frequencies, percentages, 
means (for normally 
distributed data), and 
medians (for non‐normal 
data) with between‐
sample comparisons 
conducted using standard 
parametric or 
nonparametric tests, as 
appropriate. Fisher exact 
and χ2 tests were used to 




and readmission rates 
between groups. 
Statistical analyses were 
conducted using SAS v9.3 
(SAS Institute). 
Among all HF 
discharges, 25% 
were done with 
residual congestion 
Among discharges 




discharged on less β‐
blocker and 46% 









was the most 
common reason for 
discharge with 
residual congestion, 
and hypotension was 
the most common 
reason for discharge 
with no or decreased 
neurohormonal 
therapy. Recent 
inotropic use was 
also commonly cited 
at the academic 
hospital. 
Clinicians frequently deviate from 
guidelines at both academic and 
community hospitals. However, this 
may not always indicate poor‐quality 
care. Application of traditional HF 
guidelines, which were developed in 
stable HF populations, at the time of 
hospital discharge is increasingly 
limited by hypotension, renal 
dysfunction, and recent inotrope use in 
more tenuous HF patients. Patients 
with renal dysfunction, hypotension, 
and recent inotrope use merit further 
study to determine best practices and 






What are the 
trends in 30-day, 
all-cause 
readmission rates 
from 2009 to 
2012 among 
patients with 
heart failure and 





None Patients were included 
if they were discharged 
on or before November 
1 of each calendar 
year. Patients were 
excluded from the 
analysis if they were 
ineligible for fee-for-
service Medicare at the 
time of discharge from 
the index 
hospitalization, they 
died in hospital, their 
discharge status was 
missing or not 
Combined data from the 
GWTG-HF registry, the 
American Hospital 
Association Survey on 
Hospital Characteristics, 
the Dartmouth Atlas of 
Healthcare, CMS 
administrative claims, and 
the CMS Hospital 
Compare data. 
Presented categorical 
variables as frequencies 
and percentages and 
continuous variables as 










the most to 




There has been slight improvement in 
30-day all-cause readmission rates in 
patients with heart failure, few 
hospitals have seen large success. 
More research is needed to understand 
how to improve hospital readmission 
for patients with heart failure 
regarding how to identify and 
implement best practices nationally. 
 50 
documented, they left 
against medical advice, 
or they were 
transferred to an acute 
care facility. Hospitals 
were excluded if they 
had fewer than 10 
patients in GWTG-HF 
program in 2009 or 
2012. 
and interquartile ranges. 
Compared categorical 
variables using Fisher 
exact test. Compared 
continuous variables 
using Kruskal–Wallis 
tests. Evaluated the 
relationship between 
baseline readmission rates 
and relative rate reduction 
by calculating relative 
change in 30-day risk-
adjusted readmission rates 
between 2009 and 2012 as 
a function of quartiles of 
2009 risk-adjusted 
readmission rates using a 
Kruskal–Wallis test. 
Determined trends across 
admission years using an 
unadjusted linear 
regression model with 
generalized estimating 
equation to account for in-
hospital clustering, with 
percent readmission as the 
outcome and admission 
year as the explanatory 
variable. Performed a 
sensitivity analysis 
designed to ensure that 
our study population had 
similar rates of relative 
change in readmissions to 
hospitals nationwide. 













None Compared hospital 
performance of the 
Centers for Medicare 
& Medicaid Services 
AMI and HF core 
measures in 283 
hospitals submitting 10 
or more patients to the 
Get With The 
Guidelines AMI and 
HF programs between 
January 2005 and April 
2009.  
Data were collected via a 
web-based patient 
management tool that 
provides decision support 
with real-time online 
reporting features. 
Descriptive statistics were 
used to characterize 
hospital-level 
performance of AMI and 
HF core measures. The 
correlation between 
hospital performance in 
AMI measures and 
Found only a modest 
correlation between 
a hospital’s 
performance in AMI 
measures compared 
with its performance 
in HF measures. 
However, centers 
that excel at both 
AMI and HF 
measures have better 
performance than 
centers that excel at 
neither or at each 
Refining of quality improvement 
strategies is needed to optimize the 
consistency of hospital quality of 
cardiovascular care. Assessments of 
hospital performance may be aligned 
better with the overall quality of 
inpatient cardiovascular care, rather 
than the delivery of care within a 
specific therapeutic area.  
 51 
hospital performance in 









et al., 2014. 
Level III 
Grade B 
What is the 
impact of the 
Plus Awards on 
overall quality of 





None Identified all patients 
hospitalized with heart 





reported and those 
from hospitals that did 
not report medical 
history data routinely, 
patients who died 
during hospitalization, 
and those who were 
transferred to another 
healthcare or acute care 
facility or who left 
against medical advice. 
Patient and hospital 
characteristics, 
achievement, and quality 
measures were 
summarized descriptively 
for the preprogram and 
program periods. P values 
were based on Pearson 
chi‐square tests or 
Wilcoxon tests. Logistic 
regression was used to 
assess the relationship 
between increasing 
calendar time in months 
and odds of outcome. A 
secondary analysis 
examined differences in 
use of the 9-quality 
metrics between Plus 
Awards and non‐Plus 
Awards hospitals. 
Analyses were performed 
using SAS software 
(version 9.2; SAS 
Institute). 
The study did not 




following onset of 
the program. There 
was continued 
improvement in the 
achievement 
measures with no 
erosion in 
performance on any 
of these key metrics. 





use) and others 
decelerating 
(vaccinations). 
Increases in all quality measures were 
observed over time; however, the use 
of several treatments remained low, 
including use of hydralazine–nitrate 
combination for patients of African 
descent and aldosterone antagonists in 
appropriate candidates. Given the 
underlying societal trends toward 
increasing use of most guideline‐
recommended therapies, it is important 
to examine the change in rate of 
increase with any intervention 





How effective is 
the treatment of 




dialysis in the 
inpatient setting? 
None Patients were identified 




CM code 586.6 for 
ESRD and 
ICD-9-CM codes for 
HfrEF. Patients were 
included if 
they were at least 18 
years of age, had a 
diagnosis of 
ESRD requiring 
hemodialysis (HD) or 
peritoneal dialysis 
(PD), had a diagnosis 
of HfrEF or had a 
documented 
Patient demographics and 
comorbidities were 
collected for all patients. 
Any HF med that was 
administered to a patient 
while hospitalized, as 
documented in the 
electronic medication 
administration 
record, was collected to 
determine if patients 
continued 




were also collected from 
the discharge summary to 
determine whether 




decrease of LOS in 
the GDMT Current 
guidelines 
recommend standard 
therapy for patients 
with HfrEF and 
ESRD these 
guidelines are not 
routinely being 
followed. 
Investigations need to be made into 
why ESRD and HfrEF patients are not 
receiving GDMT. 
 52 
ejection fraction of 
40% within a year prior 
to admission, and had a 
hospital 
length of stay (LOS) of 
at least 3 days. Patients 
were 
excluded if they were 
admitted directly to an 
intensive 
care unit, were 
pregnant, had a history 
of kidney 
transplant, or were 
diagnosed with ESRD 
within 3 
months of admission. 
patients were prescribed 
HF therapy at discharge. 
Statistical tests used to 
analyze baseline 
characteristics and study 
outcomes were the chi 
square, Fisher’s 
exact test or Mann-
Whitney U test where 
appropriate, by 
means of the Minitab 
statistical software. 
Yamaguchi 
et al., 2018. 
Level II 
Grade B 
What is the status 
of GDMT at the 
time of discharge 
in patients 
hospitalized with 










None 1,682 consecutive 
patients hospitalized 
with acute HF were 
prospectively 
registered from 20 
hospitals in Japan. 
Excluded 13 patients 
with in-hospital death 
and nine patients with 
missing data on GDMT 
at discharge. 
All consecutive patients 
aged ≥ 20 years old with a 
primary diagnosis of acute 
HF hospitalized through 
the emergency department 
at participating hospitals 
were enrolled upon the 
initial hospital admission 
and were followed-up. 
Patient information at the 
time of discharge and 
prognosis within 1 year of 
discharge was 
prospectively collected. 
Data were collected up to 
December 2016. End 
points of this study were 
all-cause death and HF 
readmission within one 
year of discharge. Data 
are expressed as mean and 
standard deviation for 
normally distributed 
variables, and as median 
with interquartile range 
(IQR) for non-normally 
distributed data. 
Categorical data are 
expressed as numbers and 
percentages. The Kruskal-
Wallis test, chi-square 
tests, Kaplan-Meier 




associated with a 
lower 1-year 
mortality. Patients 
on both ACE-I/ARB 




patients on either 
ACE-I/ARB or BB. 
GDMT was not 
associated with a 
lower HF 
readmission rate 
when accounting for 
death as a competing 
risk 
Results imply that the hospitalization 
is an important time to optimize HF 
medication for patients with HF. 
 53 
estimates, log-rank test, 
Gray test, the Cox 
regression model, and the 
Hosmer-Lemeshow test 
were all used.  Statistical 
analyses were performed 















None Patients with a clinical 
diagnosis of HF or 
prior myocardial 
infarction documented 
on at least 2 separate 
visits were eligible for 
enrollment. Reduced 
LVEF was required to 
be demonstrated by a 
quantitative LVEF 
≤35% or by qualitative 
findings of moderate to 
severe left ventricular 
systolic dysfunction. 
Patients with a non-
cardiovascular medical 
condition with an 
estimated survival of 
<1 year and those who 
had undergone cardiac 
transplantation were 
excluded. 
Data were collected by 
medical chart review. A 
logistic regression model 
was used. Descriptive 
summary statistics of 
baseline patient and 
practice characteristics 
were calculated for the 
case and control groups 
and both groups 
combined. Continuous 
variables were analyzed 
using the 2‐sample t test, 
and categorical variables 
were analyzed with the 
chi‐square test. The 
unadjusted odds ratio 
(OR) of death was 
determined using a 
logistic regression model 
with the therapy as the 
predictor variable and no 
covariate adjustment. 
Analyses were completed 
with SAS statistical 
software, version 9.1. 
Individual and 






with a potential 
plateau at 4 to 5 
therapies. There was 
an incremental 





Provides further rationale to 
implement guideline‐recommended 
HF therapies in the absence of 
contraindications to patients with HF 






Is using a simple 
checklist for HF 
associated with 





None The selection of 
patients for use of the 
checklist was the 
decision of the 
attending physician or 
house staff or nurse 
practitioner taking care 
of the patient and was 
encouraged but not 
enforced to be used for 
all HF patients. 
Inclusion criteria 
included patients 
admitted with a 
primary diagnosis of 
Continuous variables are 
presented as mean 
standard deviation and 
categorical variables as 
frequencies and 
percentages. Unpaired 
Student t test was used to 
compare continuous 
variables. Test for two 
proportions and chi-
square test were used to 
compare categorical 
variables. Fisher exact test 
was used instead if any 
one value in the 
The study 
demonstrates a 
decrease in 30-day 
and 6-month 
readmission rates for 
HF patients with the 
use of the checklist.  
Use of a checklist may have a 
significant impact in enhancing quality 
of care, improving clinical outcomes, 
and, in turn, decreasing the burden on 
the health care system. 
 54 
acute decompensated 
HF from August 2008 
to October 2009. 
Exclusion criteria 
included pregnancy 
and patients younger 
than18 years. 
calculation was <5. 
Statistical tests were 
derived from Mini Tab 
15.3, version 8.  
Deschaseaux 
et al., 2016. 
Level III 
Grade B 


















None Data came from the 
administrative claims 









Adult patients (>18 
years of age) with at 
least 2 medical claims 
within 12 months on 
different dates 
corresponding to a HF 
diagnosis during the 
period from April 1, 
2009, to March 31, 
2012, were identified. 
Patients were required 
to have continuous 
enrollment in the 
database for 1 year 
before the diagnosis of 
congestive HF and at 
least 1 year of follow-
up data after the index 
date. To ensure that 
prevalent patients were 
not included, patients 
with HF diagnosis in 
the 12 months pre-
index period were 
excluded. Patients with 
multiple comorbidities 
were not excluded. 
Data were summarized 
using descriptive 
analyses. For categorical 
variables, counts and 
percentages were 
provided for each 
treatment class. No testing 
information provided. 
More than one third 
of newly diagnosed 
HF patients do not 
receive HF-specific 
medication within 
30 days following 
initial diagnosis. 
More than 60% of 
patients continued 
on the same therapy 
after all-cause or 
HF-related 
hospitalization. 
We need to understand the reasons for 
the demonstrated delay in HF 
treatment initiation and limited use of 
guideline-directed medical therapy 
after initial diagnosis.  
 55 
Legend: 
AA- Aldosterone antagonist 
ACEi/ARB- Angiotensin-converting enzyme inhibitors/Angiotensin II receptor blockers 
AMI-Acute myocardial infarction 
BB-Beta blocker 
CMS-Centers for Medicare and Medicaid Services 
ESRD-End-stage renal disease 
HF-Heart failure 
HfrEF-Heart failure with reduced ejection fraction 
GDMT-Guideline directed medical therapy 
GWTG- Get With The Guidelines 














Effect on readmission Renal dysfunction leading to 
readmission 
Leadership involvement and further 
research for performance and quality 
improvement for HF. 
Kociol et al., 
2012 
Hospitals varied significantly 
with processes of care used; 
Use of computerized 
reminders and discharge 
checklists to improve 
adherence to evidence-based 
therapies used in <50% of 
sites surveyed. 
 Only processes in the 
discharge and 
transitional care domain 
had even a modest 
association with lower 
readmission rate. 
. Results suggest a need for better evidence and 
resources dedicated to effectively achieve 
lower readmission rates. 
Gilstrap et 
al., 2018 
Clinicians frequently deviate 
from guidelines at both 
academic and community 
hospitals 
  Renal dysfunction was the 
most common reason for 
discharge with congestion, and 
hypotension the most common 






  Teaching hospitals > 
relative readmission rates 
compared with 
nonteaching hospitals; 
1.4% of hospitals 
examined in this study 
achieved a 20% 
reduction in relative 30-
day readmission rates; 
hospitals that used post 
discharge heart failure 
disease management 





Wang et al., 
2011 
 Hospitals with excellent 
performance to both 
AMI and HF processes 
had significantly longer 
duration of GWTG 
participation and less in-
hospital mortality 
   
Heidenreich 
et al., 2014 
The use of several treatments 
remained low, including use 
of hydralazine–nitrate 
combination for patients of 
African descent and 
aldosterone antagonists in 
appropriate candidates. 
   Public reporting of hospital quality may have 
a greater impact than recognition of top 
hospitals because of stigma. Joint 
Commission and CMS have measured and 
publicly reported hospital quality of care for 
more than 10 years. 
Cutshall et 
al., 2018 
Most patients with ESRD and 
HfrEF were not receiving 
GDMT 
 Shorter LOS in the 
GDMT group may be 
clinically significant 
Carvedilol remains a preferred 
agent in this 
patient population, which was 
also observed in our study 




et al., 2018 
83.7% of patients receiving 
BB at discharge, whereas 
72.5% of patients receiving 
ACE-I/ARB at discharge 
Optimization of GDMT 
before discharge was 
associated with a lower 
1-year mortality in 
patients hospitalized with 
HfrEF 
   
Fonarow et 
al., 2012 
 Strong associations 
between β‐blocker and 
ACEI/ARB use and 
improved survival. 
Individual, and 
incremental use of 
GDMT therapies was 
associated with survival 
benefit 
  Data may provide further rationale for using 
systems, performance improvement, and 
disease management programs to ensure the 
implementation of guideline‐recommended 




Use of the HF checklist 
resulted in increased use of 
ACE inhibitors/ARBs at 
discharge. 
This checklist may have 
a significant impact in 
enhancing quality of 
care, improving clinical 
outcomes, and, in turn, 
decreasing the burden on 
the health care system 
The use of an HF 
checklist was associated 
with better quality of 
care and decreased 
readmission rates for 
patients admitted with 
HF 
 Large-scale quality-improvement projects are 
needed to further validate the effects of a HF 
checklist 
Deschaseaux 
et al., 2016 
Approximately 42% of 
patients not prescribed HF-
specific treatment within 30 
days .1/3 of newly diagnosed 
HF patients do not receive 
HF-specific medication 
within 30 days following 
initial diagnosis. 
   Need for further research to better understand 
the reasons for the demonstrated delay in HF 
treatment initiation and limited use of 















































































































































ID practice problem, 
review literature, and 
appraise. 
                        
Review prospective 
project plan and literature 
results with preceptor and 
Update supportive 
evidence table 
                        
ID Key stakeholders and 
team members with 
preceptor 
                        
Speak with key 
stakeholders and obtain 
executive support 
                        
ID action plan, potential 
budget, and prospective 
time line with preceptor. 
Review evaluation and 
dissemination plan. 




and identify and discuss 
gap for needed 
organizational process 
change 
                        
ID possible limitations, 
goals and milestones with 
preceptor. Identify HER 
capability for project 
timeline. 
                        
Finalize project proposal                         
Examine IRB protocols 
with preceptor  
                        
ID Metrics from the 
measures identified from 
the internal data and set 
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Create Project Charter                         
Create Project Scope 
Statement 
                        
Review Charter and 
Scope Statement with 
preceptor 
                        
Send invites to initial 
meeting with key 
stakeholders and plan 
agenda with presentation 
materials. 
                        
Present Project to 
Stakeholders, confirm 
budget, discuss project 
plan, and participate in 
the Failure Modes and 
Effect Analysis (FMEA) 
and assess for project 
sustainability 
                        
Educate CVU staff on 
discharge protocol 
process and potential 
benefits to patient 
outcomes. 
                        
Initiate protocol on 
inpatient unit 
                        
Evaluate adherence to 
protocol, project data and 
enter into evaluation 
software. 
                        
Update key stakeholders 
on progress of project 
                        
Collect project data and 
enter into evaluation 
software 
                        
Meet with Director of IS 
to ensure correct data 
evaluation methods. 
                        
Finalize project data 
collection period and 
enter all data. Begin 
scholarly project report. 
                        
Conduct statistical 
analysis to evaluate 
reliability and feasibility 
of results. 
                        
 61 









































































































































project report and prepare 
presentation of results. 
                        
Submit project to editor.                         
Invite key stakeholders to 
presentation of results. 
                        
Finalize DNP scholarly 
project and present 
results to key 
stakeholders. 
                        
Evaluate process of 
project with preceptor 
and areas for 
improvement 
                        
Plan for submission to 
journals and conferences 











Benchmarking Measures Data 





Outcome Reduce 30-day 
readmission 







Project manager Every 30 
days after 
project start 
45% 30 days 60 days 90 days 









>95% Project manager Every week 33% 1 2 3 4 5 6 7 8 9 10 11 12 13 
Balancing Having charge 
nurse identify 




















Project manager Every 2 
weeks 
20 1st 2 weeks 
 
2nd 2 weeks 3rd 2 weeks 
 
4th 2 weeks 
 
How many 





>100% Project manager Every 2 
weeks 
0 1st 2 weeks 
 
2nd 2 weeks 3rd 2 weeks  
 
4th 2 weeks 
Financial Reduce 
readmission 







Project manager Every 30 
days after 
project start 
$146,310.00 30 days 60 days 90 days 



















Frequencies for 30-day Readmission Rate 
 
Table H2. 
Chi-square Test  
 
Table H3. 









































Number of Times Protocol Mentioned in Rounding to Physicians 
 
Table H6. 











































Figure I3.  
Letter of Approval from American Heart Association 
 
 
